Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001596771-16-000145
Filing Date
2016-08-08
Accepted
2016-08-08 16:56:41
Documents
1
Period of Report
2016-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4342
  Complete submission text file 0001596771-16-000145.txt   5723
Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Issuer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 43334 SEVEN MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address
Sooch Mina (Reporting) CIK: 0001674006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 161814931